Cargando…
Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women
Hybrid Capture II (HC-II) is a commercial human papillomavirus (HPV) detection test designed to detect 18 HPV types divided into high-risk and low-risk groups. We have tested 1647 scrapes from 1518 unselected women attending routine cytological screening by this assay for the detection of histologic...
Autores principales: | Clavel, C, Masure, M, Bory, J-P, Putaud, I, Mangeonjean, C, Lorenzato, M, Gabriel, R, Quereux, C, Birembaut, P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363085/ https://www.ncbi.nlm.nih.gov/pubmed/10424730 http://dx.doi.org/10.1038/sj.bjc.6690523 |
Ejemplares similares
-
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
por: Clavel, C, et al.
Publicado: (2001) -
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions
por: Clavel, C, et al.
Publicado: (2004) -
Correction to Lancet Oncol 2021; 22: 1518–29
Publicado: (2022) -
Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia
por: Hart, S, et al.
Publicado: (2011) -
1518. The Microbiology of Osteoarticular Infections in Patients with Sickle Hemoglobinopathies at Texas Children’s Hospital, 2011–2018
por: Ikeda, Saki, et al.
Publicado: (2019)